Literature DB >> 2490071

Iron chelators of the pyridoxal isonicotinoyl hydrazone class. III. Formation constants with calcium(II), magnesium(II) and zinc(II).

D R Richardson1, G T Hefter, P M May, J Webb, E Baker.   

Abstract

Formation constants for the calcium(II), magnesium(II) and zinc(II) complexes of the orally effective iron chelator, pyridoxal isonicotinoyl hydrazone (PIH) and three analogues, pyridoxal benzoyl hydrazone (PBH), pyridoxal p-methoxybenzoyl hydrazone (PpMBH) and pyridoxal m-fluorobenzoyl hydrazone (PmFBH) have been determined by potentiometry at 25 degrees C and I = 0.1 M [KNO3]. The four ligands bind calcium(II) weakly and magnesium(II) only slightly more strongly, as a 1:1 complex which is formed at pH greater than 8. The chelation of zinc(II) for all the ligands studied was greater than that for calcium(II) and magnesium(II), with complexation generally becoming significant at about pH 5. Thus, chelation of zinc(II) but not calcium(II) or magnesium(II) at physiological pH, 7.4 may be expected. Calculated values of the concentration of uncomplexed metal ion indicate that the selectivity of these ligands towards Fe(III) is comparable to that of the clinically used chelator desferrioxamine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2490071     DOI: 10.1007/bf01142555

Source DB:  PubMed          Journal:  Biol Met        ISSN: 0933-5854


  16 in total

1.  The use of glass electrodes for the determination of formation constants--II: Simulation of titration data.

Authors:  P M May; K Murray; D R Williams
Journal:  Talanta       Date:  1985-06       Impact factor: 6.057

2.  Effect of pyridoxal isonicotinoyl hydrazone and analogs on iron metabolism in hepatocytes and macrophages in culture.

Authors:  D Richardson; E Baker; P Ponka; P Wilairat; M L Vitolo; J Webb
Journal:  Birth Defects Orig Artic Ser       Date:  1988

Review 3.  The present status of chelating agents in medicine.

Authors:  P M May; R A Bulman
Journal:  Prog Med Chem       Date:  1983

4.  A study of intracellular iron metabolism using pyridoxal isonicotinoyl hydrazone and other synthetic chelating agents.

Authors:  P Ponka; J Borová; J Neuwirt; O Fuchs; E Necas
Journal:  Biochim Biophys Acta       Date:  1979-08-22

5.  Pyridoxal complexes as potential chelating agents for oral therapy in transfusional iron overload.

Authors:  A Williams; T Hoy; A Pugh; A Jacobs
Journal:  J Pharm Pharmacol       Date:  1982-11       Impact factor: 3.765

6.  Effect of pyridoxal isonicotinoyl hydrazone and other hydrazones on iron release from macrophages, reticulocytes and hepatocytes.

Authors:  P Ponka; D Richardson; E Baker; H M Schulman; J T Edward
Journal:  Biochim Biophys Acta       Date:  1988-10-13

7.  Biliary iron excretion in rats following pyridoxal isonicotinoyl hydrazone.

Authors:  M Cikrt; P Ponka; E Necas; J Neuwirt
Journal:  Br J Haematol       Date:  1980-06       Impact factor: 6.998

Review 8.  Pyridoxal isonicotinoyl hydrazone (PIH): a promising new iron chelator.

Authors:  J Webb; M L Vitolo
Journal:  Birth Defects Orig Artic Ser       Date:  1988

9.  Pyridoxal isonicotinoyl hydrazone and analogues. Study of their stability in acidic, neutral and basic aqueous solutions by ultraviolet-visible spectrophotometry.

Authors:  D Richardson; L W Vitolo; E Baker; J Webb
Journal:  Biol Met       Date:  1989

10.  Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture.

Authors:  E Baker; M L Vitolo; J Webb
Journal:  Biochem Pharmacol       Date:  1985-09-01       Impact factor: 5.858

View more
  9 in total

Review 1.  Application of metal coordination chemistry to explore and manipulate cell biology.

Authors:  Kathryn L Haas; Katherine J Franz
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

2.  Cytotoxic analogs of the iron(III) chelator pyridoxal isonicotinoyl hydrazone: effects of complexation with copper(II), gallium(III), and iron (III) on their antiproliferative activities.

Authors:  D R Richardson
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

3.  Small Molecule Chelators Reveal That Iron Starvation Inhibits Late Stages of Bacterial Cytokinesis.

Authors:  Thiago M A Santos; Matthew G Lammers; Maoquan Zhou; Ian L Sparks; Madhusudan Rajendran; Dong Fang; Crystal L Y De Jesus; Gabriel F R Carneiro; Qiang Cui; Douglas B Weibel
Journal:  ACS Chem Biol       Date:  2017-12-20       Impact factor: 5.100

4.  Roots of Iron-Efficient Maize also Absorb Phytosiderophore-Chelated Zinc.

Authors:  N. Von Wiren; H. Marschner; V. Romheld
Journal:  Plant Physiol       Date:  1996-08       Impact factor: 8.340

5.  Interactions of the pyridine-2-carboxaldehyde isonicotinoyl hydrazone class of chelators with iron and DNA: implications for toxicity in the treatment of iron overload disease.

Authors:  Timothy B Chaston; Des R Richardson
Journal:  J Biol Inorg Chem       Date:  2003-02-05       Impact factor: 3.358

6.  Derivatives of Procaspase-Activating Compound 1 (PAC-1) and their Anticancer Activities.

Authors:  Howard S Roth; Paul J Hergenrother
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

Review 7.  Iron deprivation in cancer--potential therapeutic implications.

Authors:  Jessica L Heath; Joshua M Weiss; Catherine P Lavau; Daniel S Wechsler
Journal:  Nutrients       Date:  2013-07-24       Impact factor: 5.717

8.  Lysosomal iron modulates NMDA receptor-mediated excitation via small GTPase, Dexras1.

Authors:  Rachel S White; Anup K Bhattacharya; Yong Chen; Madeleine Byrd; Mary F McMullen; Steven J Siegel; Gregory C Carlson; Sangwon F Kim
Journal:  Mol Brain       Date:  2016-04-14       Impact factor: 4.041

9.  Enterobactin induces the chemokine, interleukin-8, from intestinal epithelia by chelating intracellular iron.

Authors:  Piu Saha; Beng San Yeoh; Xia Xiao; Rachel M Golonka; Ahmed A Abokor; Camilla F Wenceslau; Yatrik M Shah; Bina Joe; Matam Vijay-Kumar
Journal:  Gut Microbes       Date:  2020-11-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.